This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Activity Details

283 * ! Tue, 8/3/2010, 8:30 AM - 10:20 AM CC-207 (West)
Joint Modeling of Time-to-Event and PROs in Oncology Clinical Trials — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Wei Shen, Eli Lilly and Company, Grace Y. Yi, University of Waterloo
Chair(s): Wei Shen, Eli Lilly and Company
8:35 AM Joint Analysis of Symptom and Progression-Free Survival Endpoints in Previously Treated Malignant Pleural Mesothelioma — Michelle D. Hackshaw, Walden University ; Mark E. Boye, Eli Lilly and Company ; Teena M. West, Eli Lilly and Company ; Angela W. Prehn, Walden University ; Wei Shen, Eli Lilly and Company ; Luping Zhao, Eli Lilly and Company
8:55 AM One Scenario in Which Joint Modeling Is Unnecessary — Joel A. Dubin, University of Waterloo ; Xiaoqin Xiong, University of Waterloo
9:15 AM Application of Bayesian Joint Modeling of Time-to-Event and Patient-Reported Outcomes in an Oncology Clinical Trial — Luping Zhao, Eli Lilly and Company ; Wei Shen, Eli Lilly and Company ; Haoda Fu, Eli Lilly and Company ; Michelle Denise Hackshaw, Eli Lilly and Company ; Mark E. Boye, Eli Lilly and Company
9:35 AM A Frailty-Model-Based Approach to Estimating the Age-Dependent Penetrance Function of a Gene Mutation Using Family-Based Study Designs — Yun-Hee Choi, The University of Western Ontario ; Laurent Briollais, Samuel Lunenfeld Research Institute
9:55 AM Nonparametric MLE for Doubly Censored Data with Frailty — Yu-Ru Su, University of California, Davis ; Jane-Ling Wang, University of California, Davis
10:15 AM Floor Discussion



2010 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.